New FDA guidance includes updates for assessing patient-reported outcomes in cancer trials. New draft guidance for industry highlights core patient-reported outcomes (PROs) and considerations for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback